drugset / Trial / NCT02119728
Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized phase II trial studies how well photodynamic therapy with HPPH works in treating patients with squamous cell carcinoma of the oral cavity. Photodynamic therapy uses HPPH that becomes active when it is exposed to a certain kind of light. When the drug is active, cancer cells are killed. This may be effective against squamous cell carcinoma of the oral cavity.
Timeline
- Start
- —
- Primary completion
- 2017-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-(1-HEXYLOXYETHYL)-2-DEVINYL PYROPHEOPHORBIDE-A | Unknown | — | Intravenous |